Mesa Laboratories (NASDAQ:MLAB) had declared a cash dividend of $0.1600 on Apr 12, 2016. The shares will quote ex-dividend on May 26, 2016 and the record date has been fixed on May 31, 2016. At Apr 12, 2016 share price, the yield comes out to be 0.6603%. The dividend payable date has been fixed on Jun 15, 2016.
In a different note, Janney Capital said it Initiates Coverage on Mesa Laboratories, according to a research note issued on Feb 10, 2016. The shares have been rated ‘Buy’ by the firm.
Mesa Laboratories (MLAB) shares turned negative on Fridays trading session with the shares closing down -2.27 points or -2.31% at a volume of 73,042. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $100.13. The peak price level was also seen at $100.13 while the days lowest was $94.235. Finally the shares closed at $95.8. The 52-week high of the shares is $126.045 while the 52-week low is $73.5. According to the latest information available, the market cap of the company is $347 M.
Mesa Laboratories(MLAB) last announced its earnings results on Aug 3, 2015 for Fiscal Year 2016 and Q1.Company reported revenue of $18.16M. Analysts had an estimated revenue of $18.78M. Earnings per share were $0.85. The reported EPS was above estimates by $0.02 or 2.41. Analysts had estimated an EPS of $0.83.
Several Insider Transactions has been reported to the SEC. On Mar 9, 2016, H Stuart Campbell (director) sold 280 shares at $90.00 per share price.Also, On Nov 9, 2015, John James Sullivan (President and CEO) sold 2,400 shares at $112.99 per share price.On Sep 17, 2015, Robert V Dwyer (director) sold 2,000 shares at $113.00 per share price, according to the Form-4 filing with the securities and exchange commission.
Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.